Induction of Adipophilin-Specific Cytotoxic T Lymphocytes Using a Novel HLA-A2-Binding Peptide That Mediates Tumor Cell Lysis

Cancer Research

Volumn 64, Issue 3, 2004, Pages 1164-1170

  Schmidt, Susanne M ^a   Schag, Kerstin ^a   Müller, Martin R ^a   Weinschenk, Toni ^b   Appel, Silke ^a   Schoor, Oliver ^b   Weck, Markus M ^a   Grünebach, Frank ^a   Kanz, Lothar ^a   Stevanovic, Stefan ^b   Rammensee, Hans Georg ^b   Brossart, Peter ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Interfaculty Institute for Cell Biology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOPHILIN; BINDING PROTEIN; CANCER VACCINE; CELL PROTEIN; EPITOPE; HLA A2 ANTIGEN; RNA; UNCLASSIFIED DRUG;

ADIPOCYTE; ARTICLE; B LYMPHOCYTE; CANCER CELL; CELL TYPE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DRUG DESIGN; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR CELL; TUMOR CELL CULTURE;

ANTIGEN PRESENTATION; CELL LINE, TUMOR; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; HLA-A ANTIGENS; HUMANS; NEOPLASMS; PEPTIDES; RNA; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 10744230512     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2538     Document Type: Article

References (19)

1. Gilboa, E. The makings of a tumor rejection antigen. Immunity, 11: 263-270, 1999.
2. Brossart, P., Wirths, S., Brugger, W., and Kanz, L. Dendritic cells in cancer vaccines. Exp. Hematol., 29: 1247-1255, 2001.
3. Jager, E., Jager, D., and Knuth, A. Clinical cancer vaccine trials. Curr. Opin. Immunol., 14: 178-182, 2002.
4. Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., and Schadendorf, D. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med., 4: 328-332, 1998.
5. Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., and Levy, R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med., 2: 52-58, 1996.
6. Thurner, B., Haendle, I., Roder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A., Maczek, C., Schreiner, D., von den Driesch, P., Brocker, E. B., Steinman, R. M., Enk, A., Kampgen, E., and Schuler, G. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med., 190: 1669-1678, 1999.
7. Brossart, P., Wirths, S., Stuhler, G., Reichardt, V. L., Kanz, L., and Brugger, W. Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells. Blood, 96: 3102-3108, 2000.
8. Holtl, L., Zelle-Rieser, C., Gander, H., Papesh, C., Ramoner, R., Bartsch, G., Rogatsch, H., Barsoum, A. L., Coggin, J. H., Jr., and Thurnher, M. Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells. Clin. Cancer Res., 8: 3369-3376, 2002.
9. Weinschenk, T., Gouttefangeas, C., Schirle, M., Obermayr, F., Walter, S., Schoor, O., Kurek, R., Loeser, W., Bichler, K. H., Wernet, D., Stevanovic, S., and Rammensee, H. G. Integrated functional genomics approach for the design of patient-individual antitumor vaccines. Cancer Res., 62: 5818-5827, 2002.
10. Heid, H. W., Moll, R., Schwetlick, I., Rackwitz, H. R., and Keenan, T. W. Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res., 294: 309-321, 1998.
11. Brown, D. A. Lipid droplets: proteins floating on a pool of fat. Curr. Biol., 11: 446-449, 2001.
12. Buechler, C., Ritter, M., Duong, C. Q., Orso, E., Kapinsky, M., and Schmitz, G. Adipophilin is a sensitive marker for lipid loading in human blood monocytes. Biochem. Biophys. Acta, 1532: 97-104, 2001.
13. Vosper, H., Patel, L., Graham, T. L., Khoudoli, G. A., Hill, A., Macphee, C. H., Pinto, I., Smith, S. A., Suckling, K. E., Wolf, C. R., and Palmer, C. N. The peroxisome proliferator-activated receptor δ promotes lipid accumulation in human macrophages. J. Biol. Chem., 276: 44258-44265, 2001.
14. Rae, F. K., Stephenson, S. A., Nicol, D. L., and Clements, J. A. Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display. Int. J. Cancer, 88: 726-732, 2000.
15. Brossart, P., Grunebach, F., Stuhler, G., Reichardt, V. L., Mohle, R., Kanz, L., and Brugger, W. Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor. Blood, 92: 4238-4247, 1998.
16. Brossart, P., Heinrich, K. S., Stuhler, G., Behnke, L., Reichardt, V. L., Stevanovic, S., Muhm, A., Rammensee, H. G., Kanz, L., and Brugger, W. Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies. Blood, 93: 4309-4317, 1999.
17. Brossart, P., Stuhler, G., Flad, T., Stevanovic, S., Rammensee, H. G., Kanz, L., and Brugger, W. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes. Cancer Res., 58: 732-736, 1998.
18. Schmidt, S. M., Schag, K., Muller, M. R., Weck, M. M., Appel, S., Kanz, L., Grunebach, F., and Brossart, P. Survivin is a shared tumor associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T-cells. Blood, 102: 571-576, 2003.
19. Grünebach, F., Müller, M. R., Nencioni, A., and Brossart, P. Delivery of tumor derived RNA for induction of cytotoxic T-lymphocytes. Gene Ther., 10: 367-374, 2003.